June 22, 2011 | Filed under: Health,News | Posted by:
Testing chemicals to determine their impact on breast development and breast cancer risk should be a standard part of the regulatory process, according to a new report.
Posted by
on June 22, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.